Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep/Oct;27(5):e556-e558.
doi: 10.1097/MJT.0000000000000830.

Agomelatine Use in Child and Adolescent Psychiatry

Ahmed Naguy  1 , Bibi Alamiri  2   3   4
Affiliations
Review

Agomelatine Use in Child and Adolescent Psychiatry

Ahmed Naguy et al. Am J Ther. 2020 Sep/Oct.
No abstract available

PubMed Disclaimer

References

    1. de Bodinat C, Guardiola-Lemaitre B, Mocaer E, et al. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov. 2010;9:628–642.
    1. Olie JP, Kasper S. Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol. 2007;10:661–673.
    1. Pae CU. Agomelatine: a new option for treatment of depression?. Expert Opin Pharmacother. 2014;15:443–447.
    1. Guardiola-Lemaitre B, De Bodinat C, Delagrange P, et al. Agomelatine: mechanism of action and pharmacological profile in relation antidepressant properties. Br J Pharmacol. 2014;171:3604–3619.
    1. Niederhofer H. Treating ADHD with agomelatine. J Atten Disord. 2012;16:346–348.

MeSH terms